Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer: a Prospective, Observational Study

NCT06609759 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06609759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06609759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Postoperative Adjuvant Therapy for Stage II-III Gastric Cancer: a Prospective, Observational Study
Lead sponsor
Qilu Hospital of Shandong University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2024
Completion date
January 1, 2029
Enrollment
197 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

stage ii-iii gastric cancer